Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1129 of 5804
-
Shigella vaccine immunity checked years later in african kids
⭐️ VACCINE ⭐️ Not yet recruitingThe current study is a follow-up to 2 previous parent studies, a dose-selection study with 3 different dose-levels of the altSonflex1-2-3 vaccine in a schedule of 3 vaccinations (H06\_01TP study \[NCT05073003, 212149\]) and a study with an alternate 2 vaccination schedule H06\_02…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
New pill could tame deadly heart flutters during exercise
Disease control Recruiting nowThis trial is conducted in patients with an inherited heart rhythm disorder called catecholaminergic polymorphic ventricular tachycardia (CPVT). This condition causes the heart to beat dangerously fast during situations of physical or emotional stress. CPVT is a serious condition…
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Glow-in-the-Dark dye may help surgeons spot hidden tumor cells
Diagnosis Recruiting nowThis study evaluates the diagnostic accuracy of Indocyanine Green (ICG) fluorescence imaging in visualizing Tenosynovial Giant Cell Tumor (TGCT) lesions during surgery. Patients diagnosed with TGCT will receive an intravenous injection of ICG prior to the operation to label tumor…
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Shocking the nose back to life: new combo therapy for Parkinson's smell loss
Symptom relief CompletedBackground: Olfactory and gustatory impairments are common clinical manifestations in patients with neurodegenerative conditions like Parkinson's disease. These chemosensory deficits significantly impact the quality of life, often preceding motor symptoms. Currently, there is a …
Phase: NA • Sponsor: Mustafa Baran • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New hope for tough leukemia? early trial combines three drugs
Disease control Recruiting nowIMAGINE is a two-part trial to evaluate the safety and preliminary efficacy of imetelstat in combination with azacitidine with or without venetoclax in patients with relapsed or refractory AML. The trial will consist of a safety run-in phase (Part A) employing a 3+3 design to mon…
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Freeze your pain away: new procedure before knee surgery shows promise
Symptom relief Recruiting nowApproximately 20-30% of patients experience persistent pain after a Total Knee Arthroplasty (TKA). This study investigates whether percutaneous cryoneurolysis of genicular nerves can reduce pain and improve physical function when performed at least 24 hours before surgery. Partic…
Phase: NA • Sponsor: Attikon Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Virtual reality workouts could help older adults stay steady on their feet
Symptom relief Not yet recruitingThis study will compare two exercise-based rehabilitation programs to improve balance and reduce fall risk in adults aged 45 years and older who have had at least one fall in the past year or have balance problems. Participants will be assigned to one of two groups: (1) a virtual…
Phase: NA • Sponsor: Umm Al-Qura University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New hope for rare amyloidosis: targeted drug combo enters trial
Disease control Not yet recruitingThe goal of this study is to evaluate the efficacy and safety of Sonrotoclax combined Regimen in patients with t(11;14) AL amyloidosis. Participants will receive the Sonrotoclax Plus Dexamethasone regimen with or without Daratumumab for 12 cycles. The Hematologic Response, Organ …
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study tests freezing vs. heating nerves to ease war wound pain
Symptom relief Recruiting nowThis study is a multicenter clinical trial conducted in Vinnytsia, Rivne, and Lviv, Ukraine, focusing on the management of acute pain following thoracic injuries sustained during combat. The main purpose of the study is to evaluate and compare the effectiveness and safety of two …
Phase: NA • Sponsor: Lviv National Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New gel could stop tooth decay in preschoolers
Prevention OngoingThe objective is to compare the efficacy of SDF gel with that of NaF varnish in preventing carious lesions in preschool children when applied at half-yearly intervals over a 24-month period.
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New hope against drug-resistant lung bacteria? rifabutin trial begins
Disease control Recruiting nowBackground: Mycobacterium abscessus, one of the most common species of nontuberculous mycobacterium (NTM), poses a significant clinical challenge due to its natural resistance to antibiotics and high treatment failure rates, particularly in lung diseases. Among its subspecies, M.…
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can AI help doctors spot diseases faster and better?
Diagnosis Recruiting nowThis study aims to evaluate the diagnostic performance and clinical utility of a multimodal medical imaging large model in identifying common systemic diseases. Through a retrospective reader study involving multiple centers, the research will compare the diagnostic accuracy, sen…
Sponsor: The Third Affiliated Hospital of Southern Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Walking with a smartwatch may sharpen aging minds and ease loneliness
Disease control CompletedParticipants in the wearable-assisted walking group were asked to walk five days per week for approximately 30 minutes per session at moderate intensity. An Apple Watch was used to monitor daily steps, walking duration, and estimated energy expenditure. Participants also received…
Phase: NA • Sponsor: National Taiwan College of Performing Arts • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI and blood tests join forces to crack the code of hormone disorders
Diagnosis Not yet recruitingHyperandrogenism is a common reason for consultation, the causes of which can range from common conditions (PCOS) to rarer conditions with major genetic implications (NC21OHD). It is characterized by elevated levels of circulating androgens, mainly testosterone. This excess of an…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Healing heel bone infections: could an antibiotic bone graft be the key?
Disease control Recruiting nowThe ACHILLS Trial is a multicentre randomised controlled feasibility study comparing partial calcanectomy with and without the use of an antibiotic-impregnated bone graft substitute (Cerament G) for treating calcaneal osteomyelitis, specifically on wound healing rates, re-infecti…
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can the RSV vaccine protect the most vulnerable? new study aims to find out
Disease control Not yet recruitingThis study evaluates whether the RSV vaccine Abrysvo can produce an antibody response in patients with blood cancers who have previously received a hematopoietic stem cell transplant (HSCT) or CAR-T cell therapy. The vaccine targets the prefusion F (preF) protein of RSV, which is…
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could magnetic pulses to the brain help kids with ADHD and autism?
Symptom relief Not yet recruitingThis double-blind, randomized, sham-controlled clinical trial will evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) on children and adolescents with attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) and matched healthy co…
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New pill targets cancer growth pathway in advanced tumors
Disease control Not yet recruitingThis study is to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of the TEAD inhibitor TYK-01054 capsules in patients with locally advanced or metastatic advanced solid tumors
Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Jail-to-Freedom: cash rewards could keep opioid patients alive
Disease control Not yet recruitingPeople leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a progra…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Robotic glove could help stroke survivors regain hand control
Symptom relief Recruiting nowThe goal of this clinical trial is to investigate the feasibility of using the Soft Forearm Robot system for wrist and forearm recovery of hemiplegic subjects suffered from stroke. Participant will attend 20 training sessions and 3 assessment sessions. This system will leverage …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC